BioCentury
ARTICLE | Company News

Epizyme, GlaxoSmithKline deal

April 28, 2014 7:00 AM UTC

Epizyme will receive a $4 million milestone payment from GlaxoSmithKline under a 2011 deal in which the companies partnered to discover, develop and commercialize small molecule therapeutics targeting...